Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
According to Sudarshan Sukhani of s2analytics.com, one may avoid Wockhardt.
Bino Pathiparampil, vice president-research, IIFL views come on a day when the stock has tanked 20 percent on the back of the USFDA‘s warnings over the pharma major‘s manufacturing practices.
Mayuresh Joshi, VP Institution of Angel Broking recommends selling Wockhardt on rally and look for stocks within pharmaceutical or consumer durables.
Abhishek Agarwal of Fortune Interfinance recommends buying Wockhardt and advises to buy Tech Mahindra with a target price of Rs 1,220 and a stop loss of Rs 1,165.
Abhishek Agarwal of Fortune Interfinance advised buying Wockhardt with a target price of Rs 880 and Tech Mahindra with a target price of Rs 1220.
Sriram Rathi of Anand Rathi suggests holding Wockhardt. "One should wait for any fresh buying because there will be no positive trigger for next two-three quarters," he adds.
Rajesh Agarwal, Head of Research of Eastern Financiers is of the view that one may hold Wockhardt.
Rathi recommends booking profit in Lupin at current valuations. He has a neutral rating and a ‘hold‘ on the Sun Pharma stock because there are several triggers which can drive the earning surprise positively
Sudarshan Sukhani of s2analytics.com recommends selling Wockhardt as the stock has broken down from the trading range and expects more downside in it.
Aashish Tater, Head of Research of Fortunewizard.com says one can buy Wockhardt with a long term perspective if the stock sees Rs 800-820 levels.
Dipan Mehta Member of BSE and NSE recommends to stay away from Wockhardt as the stock will continue to remain under stress.
Sanjeev Agarwal, CEO of Dynamix Research & Capital Management advises buying Lupin as it may touch Rs 1000 quite easily. He, however, advises avoiding Wockhardt.
Ambareesh Baliga of Edelweiss Financial Services feels Reliance Communications could see Rs 145-150 levels.
Prashant Nair of Citi India told CNBC-TV18 that the pharma sector's valuations in current market downturn situation has held up well. He presents his views on buzzing stocks from the sector.
Dipan Mehta is overweight on IT sector with rupee depreciating. Among the pharma stocks, he likes Sun Pharma, Dr Reddy's, Wockhardt and Cadila.
Sudarshan Sukhani of s2analytics.com feels Wockhardt may test Rs 1,300 in one year timeframe. However, short term investor should exit the stock.
Sudarshan Sukhani of s2analytics.com advises to buy Wockhardt with deep stop loss.
Rajen Shah, CIO at Angel Broking is of the view that one can see modest upside in Wockhardt. "At this level it is trading at just about 10 times the current year earnings. So nothing much to lose from the current levels,"he adds.
SP Tulsian of sptulsian.com is bullish on Britannia Industries and recommends buying the stock with a day target of Rs 609 and stop loss of Rs 569.
Rajen Shah is positive on L&T, Crompton Greaves, Jet Airways, but advises investors to stay away from commodity related stocks like Tata Steel.
Saurabh Mittal of Swadeshi Capital advised buying YES Bank with a target price of Rs 515. Meanwhile, Nooresh Merani of AMSEC Research advised buying Dena Bank with a target price of Rs 92.
Sudarshan Sukhani of s2analytics.com advised short-term traders to go long in Wockhardt with a stoploss. He feels the uptrend in the stock is intact.
SP Tulsian of sptulsian.com says he is positive on Sun Pharma as well as Wockhardt, but he will prefer the latter one for short term.
Wockhardt may settle around Rs 1300-1350, says SP Tulsian of sptulsian.com.
Aashish Tater of FortuneWizard.com advised holding Wockhardt. According to him, the stock can go upto Rs 1650-1750 in next one year.